Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Authors

Mark J. Mulligan, New York University Langone Vaccine Center
Kirsten E. Lyke, University of Maryland School of Medicine
Nicholas Kitchin, Pfizer Limited, UK
Judith Absalon, Pfizer Inc.
Alejandra Gurtman, Pfizer Inc.
Stephen Lockhart, Pfizer Limited, UK
Kathleen Neuzil, University of Maryland School of Medicine
Vanessa Raabe, New York University Langone Vaccine Center
Ruth Bailey, Pfizer Limited, UK
Kena A. Swanson, Pfizer Inc.
Ping Li, Pfizer Inc.
Kenneth Koury, Pfizer Inc.
Warren Kalina, Pfizer Inc.
David Cooper, Pfizer Inc.
Camila Fontes-Garfias, UT Medical Branch at Galveston
Pei Yong Shi, UT Medical Branch at Galveston
Özlem Türeci, BioNTech SE
Kristin R. Tompkins, Pfizer Inc.
Edward E. Walsh, University of Rochester
Robert Frenck, Cincinnati Children's Hospital Medical Center
Ann R. Falsey, University of Rochester
Philip R. Dormitzer, Pfizer Inc.
William C. Gruber, Pfizer Inc.
Uğur Şahin, BioNTech, Mainz, Germany
Kathrin U. Jansen, Pfizer Inc.

Department

Infectious Diseases

Document Type

Erratum

Publication Title

Nature

Abstract

Erratum for: Nature. 2020 Oct;586(7830):589-593. PMID: 33469216.

In the print version of this Article, some of the symbols were corrupted in Fig. 4. The HTML and PDF versions of the Article were correct, and so the original Article has not been corrected online.

DOI

10.1038/s41586-020-03098-3

Volume

590

Publication Date

2-2021

Recommended Citation

Mulligan, M., Lyke, K., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K., Li, P., Koury, K., Kalina, W., Cooper, D., Fontes-Garfias, C., Shi, P., Türeci, Ö., Tompkins, K., Walsh, E., Frenck, R., Falsey, A., Dormitzer, P., Gruber, W., Şahin, U., & Jansen, K. (2021). Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature, 590 https://doi.org/10.1038/s41586-020-03098-3